During the management of a 3 kg term black female infant whose chylothorax was diagnosed at 7 days of age, a total of 450 ml of chyle was removed by repeated thoracentesis before spontaneous heal ing occured. The total n mber of lymphocytes removed Y during 18 days was greater than 10 . Monoclonal antibody studies showed 95% of these cells were T-lymphocytes which were functionally immature as evidenced by their non-responsiveness to mitogen. There was no associated peripheral blood lymphopenia. Nevertheless, peripheral T-cells were abnormal as shown by lack of sheep RBC rosette formation and lack of response to mitogens. The thymus which was absent during the 18 days of therapy, reappeared 2 weeks after disappearance of the chylothorax accompanied by normalization of peripheral T-lymphocyte functions.
Y during 18 days was greater than 10 . Monoclonal antibody studies showed 95% of these cells were T-lymphocytes which were functionally immature as evidenced by their non-responsiveness to mitogen. There was no associated peripheral blood lymphopenia. Nevertheless, peripheral T-cells were abnormal as shown by lack of sheep RBC rosette formation and lack of response to mitogens. The thymus which was absent during the 18 days of therapy, reappeared 2 weeks after disappearance of the chylothorax accompanied by normalization of peripheral T-lymphocyte functions.
Loss of large volumes of chyle in congenital idiopathic chylothorax can cause transient severe depletion of T-lymphocytes associated with cell mediated immune deficiency as evidenced by a decrease in T-cell forming rosettes with either sheep RBC or lymphoblastoid B cell lines, and functional tests of cellular imnunity. Detroit.
RADIONUCLIDE SCANS (RS) AND
Intravenous administration of ritodrine has been shown to prolong pregnancy in selected patients. However the drug has been associated with maternal cardiovascular and mLtabolic derangements. If tocolytic therapy fails and the neonate delivers soon after ritodrine is discontinued significant drug levels could increase neonatal morbidity.
he DurDose of this studv was to examine the following neonatal out'combs: Apgar score min. and 5 min., neonatal pH, plasma bicarbonate,hypotension, hypoglycemia, respiratory distress syndrome & neonatal mortality in infants exposed to IV ritodrine within 12 hours of delivery. Fifty-eight neonates delivered within 12 hours of discontinuing intravenous maternal ritodrine were matched for birthweight and gestational age with 58 control infants without ritodrine exposure. The study infants had a mean G+ of 32.8 + 2.8 wks & a mean BW of 1744 + 512 gm. The potentlal effect-of the total ritodrine dose used and the drug discontinuance to delivery intervals (DDDI) on the 8 neonatal outcomes were evaluated The frequencies of maternal medical and obstetric complications were similar in both groups PROM ar4 prolon ed rupt re of membranes >12 hours were moye.co&non, in t JnfroK <o.oo~). of the neonatal morbldlty variables .ammed only yp hypoglycemia occurred more frequently in the ritodrine'exposed neonates as compared to control group. Stepwise discriminant analysis and stepwise multilinear regression failed to reveal an effect of total maternal ritodrine dose, and DDDI on the occurrence of the neonatal morbidity variables. The analysis showed that gestational age was a good predictor of RDS and neonatal death but that ritodrine dose and DDDI did not add significantly to the prediction of any neonatal complications. These findings suggest that ritodrine used per protocol is not associated with a significant increase in neonatal morbidity. sick term infants. The well infants were studied on three consecutive days. Both right and left sides, and several probe sizes and probe frequencies were studied. The signal is quite reproducible between left and right sides, between studies in the same infant on different days, as well as between infants. We have determined the spectral pattern in term infants, and have, in one sick infant, identified asyrmetry between R & L when there was facial pallor during a prostaglandin infusion. This qualitative method should prove useful in monitoring cerebral blood flow in newborns. VD is not an infrequent observation during an ultrasound (US) examination of the head in LBW newborns. Very little information is available with regard to its pathogenesis, evolution and significance. We studied 59 LBW infants who were identified as having VD CVD(fj] by the first cranial US examination (US #1) which was done during the immediate neonatal period (mean age 3.03 days) and compared with 59 wt and gestation matched controls without VD [w (-)] who were selected with no knowledge of the result of US findings. US follow-up of the study and control infants are shown in the followinq tables (#, The effect of sex on perinatal mortality is well known and morbidity has been under investigation. Higher incidence of periventricular hemorrhage (PVH) in males has been reported by others. On the basis of a first cranial ultrasound (US) examination, the following sex distribution was found in this study of 59 LBW infants which was designed to examine the incidence of PVH, intraventricular hemorrhage (IVH), parenchymal (PHI hemorrhage, isolated VD and the control infants who had no lesions:
ISOLATED CEREBRAL VENTRICULAR DILATATION (VD) OF LOW

BIRTH WEIGHT (mw) NEONATE
US (+)/(-I 36 0/36 ( 0) 13/23 (36) 9/27 (25) 4/32 (11) *p<0.25, **<0.005: (+)=present, (-)=absent A similar trend persisted throughout the 2nd and 3rd US. In a separate larger study, designed to examine the incidence of VD present (+) aqainst the VD absent (-) control aroup on the basis of the first US examination, VD (+)/(-) ratio was 24/32 (43%) for females, 35/27 (57%) for males (<p<O.lO,ns). There appears to be a higher incidence of male involvement in IVH and no difference in PVH. The male preponderance in VD is not clearly demonstrated here and must be negligible if present. Higher incidence of PH in females detected here must be interpreted with caution since the number of involved cases is small.
